Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Afentanil + remazolam dosing vs sufentanil + propofol for fiberoptic bronchoscopy
ChiCTR2500106998Phase 4Recruiting
- Sponsor
- Qujiang District People's Hospital
- Start
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of alfentanil and remimazolam mesylate in bronchitis, pneumonia, lung neoplasm and 1 more (4 arms), sponsored by Qujiang District People's Hospital. Primary endpoints: SpO2 at different time points, Heart rate (HR) at different time points and 4 more. Started Aug 2025; status: recruiting.
02
Drugs
alfentanilremimazolam mesylate
03
Conditions
bronchitispneumonialung neoplasmTuberculosis (TB)
Beyond the preview
Go deeper on ChiCTR2500106998.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500106998.